Given that CGA did not modulate colitis severity in either macrophage-deleted or CY-09-treated mice, we next considered the possibility that the protective effect of CGA against colitis might be achieved by macrophage-NLRP3 axis. This evidence concerns the gene NLRP3 and colitis.